相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Does ex vivo CD34+positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?
M. C. Oliveira et al.
BONE MARROW TRANSPLANTATION (2016)
Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phase
P. O. Barros et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Effect of FOXP3 polymorphism on the clinical outcomes after allogeneic hematopoietic stem cell transplantation in pediatric acute leukemia patients
Zhe Piao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Adipose-Derived Mesenchymal Stem Cells Modulate the Immune Response in Chronic Experimental Autoimmune Encephalomyelitis Model
Sally M. Shalaby et al.
IUBMB LIFE (2016)
T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO)
Adi Vaknin-Dembinsky et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
Leukemia inhibitory factor (LIF)
Nicos A. Nicola et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Neutralizing IL-17 protects the optic nerve from autoimmune pathology and prevents retinal nerve fiber layer atrophy during experimental autoimmune encephalomyelitis
Benjamin Knier et al.
JOURNAL OF AUTOIMMUNITY (2015)
IL-21R signaling is critical for induction of spontaneous experimental autoimmune encephalomyelitis
Youjin Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Azathioprine plus corticosteroid treatment in Chinese patients with neuromyelitis optica
Wei Qiu et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
The immune balance between memory and regulatory B cells in NMO and the changes of the balance after methylprednisolone or rituximab therapy
Chao Quan et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data
Giovanna Vitaliti et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica
Melina V. Jones et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica
Fumitaka Shimizu et al.
PLOS ONE (2015)
Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica
Ayako Tasaki et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Interactions between Neutrophils, Th17 Cells, and Chemokines during the Initiation of Experimental Model of Multiple Sclerosis
Dagmara Weronika Wojkowska et al.
MEDIATORS OF INFLAMMATION (2014)
Immunology of neuromyelitis optica: a T cell-B cell collaboration
Meike Mitsdoerffer et al.
TRANSLATIONAL IMMUNOLOGY IN ASIA-OCEANIA (2013)
Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks
Akiyuki Uzawa et al.
CLINICA CHIMICA ACTA (2013)
Pivotal Roles of T-Helper 17-Related Cytokines, IL-17, IL-22, and IL-23, in Inflammatory Diseases
Ning Qu et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
High in vitro immune reactivity to Escherichia coli in neuromyelitis optica patients is correlated with both neurological disabilities and elevated plasma lipopolysaccharide levels
Priscila O. Barros et al.
HUMAN IMMUNOLOGY (2013)
The Ex Vivo Production of IL-6 and IL-21 by CD4+ T Cells is Directly Associated with Neurological Disability in Neuromyelitis Optica Patients
Ulisses C. Linhares et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
IL-21-Producing Th Cells in Immunity and Autoimmunity
Sue M. Liu et al.
JOURNAL OF IMMUNOLOGY (2013)
Serum amyloid A level is increased in neuromyelitis optica and atypical multiple sclerosis with smaller T2 lesion volume in brain MRI
Hiroaki Yokote et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
Manabu Araki et al.
MODERN RHEUMATOLOGY (2013)
Characteristic Cerebrospinal Fluid Cytokine/Chemokine Profiles in Neuromyelitis Optica, Relapsing Remitting or Primary Progressive Multiple Sclerosis
Takuya Matsushita et al.
PLOS ONE (2013)
Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica Implication for Cellular Immune Responses
Bernd C. Kieseier et al.
JAMA NEUROLOGY (2013)
Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy
Ilya Ayzenberg et al.
JAMA NEUROLOGY (2013)
Aquaporin 4-Specific T Cells in Neuromyelitis Optica Exhibit a Th17 Bias and Recognize Clostridium ABC Transporter
Michel Varrin-Doyer et al.
ANNALS OF NEUROLOGY (2012)
Cerebrospinal Fluid IL-21 Levels in Neuromyelitis Optica and Multiple Sclerosis
Aimin Wu et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2012)
Human Umbilical Cord Mesenchymal Stem Cell Therapy on Neuromyelitis Optica
Zhengjuan Lu et al.
CURRENT NEUROVASCULAR RESEARCH (2012)
Janus-like effects of type I interferon in autoimmune diseases
Robert C. Axtell et al.
IMMUNOLOGICAL REVIEWS (2012)
Mechanisms regulating regional localization of inflammation during CNS autoimmunity
Emily Pierson et al.
IMMUNOLOGICAL REVIEWS (2012)
Cerebrospinal Fluid BAFF and APRIL Levels in Neuromyelitis Optica and Multiple Sclerosis Patients During Relapse
Honghao Wang et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
18F-FDG PET Detects Inflammatory Infiltrates in Spinal Cord Experimental Autoimmune Encephalomyelitis Lesions
Dorothea Buck et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Interleukin 17 gene polymorphism is associated with anti-aquaporin 4 antibody-positive neuromyelitis optica in the Southern Han Chinese - A case control study
Honghao Wang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Variable results after rituximab in neuromyelitis optica
J. W. Lindsey et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success
Benjamin M. Greenberg et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein
Katja Herges et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Joanna Kitley et al.
NEUROLOGY (2012)
Mechanisms of Disease Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases
Erwin W. Gelfand
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Consequences of NMO-IgG binding to aquaporin-4 in neuromyelitis optica
Andrea Rossi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms
Hua Zhang et al.
ANNALS OF NEUROLOGY (2011)
Repeated Treatment With Rituximab Based on the Assessment of Peripheral Circulating Memory B Cells in Patients With Relapsing Neuromyelitis Optica Over 2 Years
Su-Hyun Kim et al.
ARCHIVES OF NEUROLOGY (2011)
Human Blood CXCR5+CD4+ T Cells Are Counterparts of T Follicular Cells and Contain Specific Subsets that Differentially Support Antibody Secretion
Rimpei Morita et al.
IMMUNITY (2011)
Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse
H. H. Wang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE
Veit Rothhammer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis
Ying Li et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Impact of rituximab on relapse rate and disability in neuromyelitis optica
Gurdesh S. Bedi et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
BAFF Promotes Th17 Cells and Aggravates Experimental Autoimmune Encephalomyelitis
Xiaohui Zhou et al.
PLOS ONE (2011)
Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
Norio Chihara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study
Gro O. Eilertsen et al.
RHEUMATOLOGY (2011)
Interferon-β exacerbates Th17-mediated inflammatory disease
Robert C. Axtell et al.
TRENDS IN IMMUNOLOGY (2011)
Current and future treatment approaches for neuromyelitis optica
Nicolas Collongues et al.
Therapeutic Advances in Neurological Disorders (2011)
Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells
Jeong Chan Ra et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Interferon Beta Treatment in Neuromyelitis Optica Increase in Relapses and Aquaporin 4 Antibody Titers
Jacqueline Palace et al.
ARCHIVES OF NEUROLOGY (2010)
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice
Samira Saadoun et al.
BRAIN (2010)
Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis
A. Uzawa et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
IL-21 and T follicular helper cells
Rosanne Spolski et al.
INTERNATIONAL IMMUNOLOGY (2010)
Enhanced IL-6 Production in Aquaporin-4 Antibody Positive Neuromyelitis Optica Patients
Sema Icoz et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2010)
Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis
Sven Jarius et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Devic's syndrome and primary APS: a new immunological overlap
D. Squatrito et al.
LUPUS (2010)
Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population
Adi Vaknin-Dembinsky et al.
MULTIPLE SCLEROSIS (2010)
Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6
Akiyuki Uzawa et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance
Sven Jarius et al.
NATURE REVIEWS NEUROLOGY (2010)
B-CELL ACTIVATING FACTOR OF THE TNF FAMILY IS UPREGULATED IN NEUROMYELITIS OPTICA
Kazumasa Okada et al.
NEUROLOGY (2010)
Proinflammatory T helper type 17 cells are effective B-cell helpers
Meike Mitsdoerffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Adipose-Tissue-Derived and Wharton's Jelly-Derived Mesenchymal Stromal Cells Suppress Lymphocyte Responses by Secreting Leukemia Inhibitory Factor
Mehdi Najar et al.
TISSUE ENGINEERING PART A (2010)
Neuromyelitis Optica: Pathogenicity of Patient Immunoglobulin In Vivo
Monika Bradl et al.
ANNALS OF NEUROLOGY (2009)
Intrathecal Pathogenic Anti-Aquaporin-4 Antibodies in Early Neuromyelitis Optica
Jeffrey L. Bennett et al.
ANNALS OF NEUROLOGY (2009)
Treatment of Neuromyelitis Optica With Mycophenolate Mofetil
Anu Jacob et al.
ARCHIVES OF NEUROLOGY (2009)
Th17 cells in rheumatoid arthritis and systemic lupus erythematosus
A. B. Pernis
JOURNAL OF INTERNAL MEDICINE (2009)
Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis
Akiyuki Uzawa et al.
JOURNAL OF NEUROLOGY (2009)
Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis
K. Yanagawa et al.
NEUROLOGY (2009)
A CASE OF NMO SEROPOSITIVE FOR AQUAPORIN-4 ANTIBODY MORE THAN 10 YEARS BEFORE ONSET
S. Nishiyama et al.
NEUROLOGY (2009)
Effects of IL-6 secreted from astrocytes on the survival of dopaminergic neurons in lipopolysaccharide-induced inflammation
Xue-zhong Li et al.
NEUROSCIENCE RESEARCH (2009)
Intermittent Plasmapheresis Prevents Recurrence in Neuromyelitis Optica
Katsuichi Miyamoto et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2009)
Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders
T. Matsushita et al.
TISSUE ANTIGENS (2009)
Autoimmune T cell responses in the central nervous system
Joan Goverman
NATURE REVIEWS IMMUNOLOGY (2009)
Neuromyelitis optica: a distinct demyelinating disease of the central nervous system
A. A. Argyriou et al.
ACTA NEUROLOGICA SCANDINAVICA (2008)
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
John S. Tzartos et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Treatment of Neuromyelitis Optica With Rituximab Retrospective Analysis of 25 Patients
Anu Jacob et al.
ARCHIVES OF NEUROLOGY (2008)
Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: Implications for Th17-mediated inflammation in auto-immunity
Chun Kwok Wong et al.
CLINICAL IMMUNOLOGY (2008)
IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition
Mark A. Kroenke et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment
Thierry Vincent et al.
JOURNAL OF IMMUNOLOGY (2008)
Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells
Michelle A. Lowes et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells
Ingunn M. Stromnes et al.
NATURE MEDICINE (2008)
Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis
M. Tanaka et al.
NEUROLOGY (2008)
Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica
Sven Jarius et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Review: Treatment of neuromyelitis optica: Current debate
Tomoko Okamoto et al.
Therapeutic Advances in Neurological Disorders (2008)
Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice
Hui-Chen Hsu et al.
NATURE IMMUNOLOGY (2008)
BAFF and MyD88 signals promote a lupuslike disease independent of T cells
Joanna R. Groom et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Neuromyelitis optica: Changing concepts
Anu Jacob et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Neuromyelitis optica
Marcelo Matiello et al.
CURRENT OPINION IN NEUROLOGY (2007)
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre
Toshiyuki Takahashi et al.
BRAIN (2007)
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis
Shanu F. Roemer et al.
BRAIN (2007)
The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease
B. Afzali et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Study of mitoxantrone for the treatment of recurrent neuromyelitis Optica (Devic disease)
Bianca Weinstock-Guttman et al.
ARCHIVES OF NEUROLOGY (2006)
B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time
A. Becker-Merok et al.
LUPUS (2006)
IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis
AI Kaplin et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis
T Ishizu et al.
BRAIN (2005)
An open label study of the effects of rituximab in neuromyelitis optica
BAC Cree et al.
NEUROLOGY (2005)
Activation of humoral immunity and eosinophils in neuromyelitis optica
J Correale et al.
NEUROLOGY (2004)
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
VA Lennon et al.
LANCET (2004)
The molecular basis of water transport in the brain
M Amiry-Moghaddam et al.
NATURE REVIEWS NEUROSCIENCE (2003)
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
CF Lucchinetti et al.
BRAIN (2002)
分享论文
